{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-001577","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2021-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.162901+00:00","generated_at":"2026-06-29T07:26:31.148408+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mednax cuts revolving credit commitments from $1.2B to $600M; no outstanding balance","bullets":["Revolving commitments reduced from $1.2 billion to $600 million effective August 23, 2021.","No outstanding principal balance on Credit Agreement as of that date.","One outstanding letter of credit of $0.1 million; available amount after reduction and minimum availability requirement is $299.9 million.","Company must maintain minimum availability of $300 million through Q3 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-001577","json":"https://secwatch.observer/filing/0000950170-21-001577.json","markdown":"https://secwatch.observer/filing/0000950170-21-001577.md","text":"https://secwatch.observer/filing/0000950170-21-001577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017021001577/0000950170-21-001577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017021001577/md-20210823.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:26:31.148408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}